This paper describes the impact of generating a homozygous inactivating mutation of the USP16 gene in a high differentiation clone of the THP-1 acute monocytic leukemia cell line, using the CRISPR-Cas9 genome editing technique. Here, USP16 is linked to acute monocytic leukemia.